Clark Capital Management Group »

Catalyst Pharmaceutical Partners shares owned by Clark Capital Management Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Clark Capital Management Group from 13F filings

Historical chart of Clark Capital Management Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Clark Capital Management Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.3M 199k 11.69
2023-06-30 $2.1M 153k 13.44
2023-03-31 $2.4M 142k 16.58

More positions owned by Clark Capital Management Group

Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Ser Tr Bloomberg High Y (JNK)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Total (IXUS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Broadcom (AVGO)
Ishares Tr Core S&p Scp Etf (IJR)
Parker-Hannifin Corporation (PH)
Chubb (CB)
Merck & Co (MRK)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)

View all positions for Clark Capital Management Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners